Arcadia Biosciences, Inc. (RKDA): Price and Financial Metrics

Arcadia Biosciences, Inc. (RKDA): $3.13

0.07 (-2.19%)

POWR Rating

Component Grades








Add RKDA to Watchlist
Sign Up

Industry: Agriculture




#24 of 28

in industry

RKDA Price/Volume Stats

Current price $3.13 52-week high $23.86
Prev. close $3.20 52-week low $3.10
Day low $3.13 Volume 3,533
Day high $3.30 Avg. volume 74,730
50-day MA $3.90 Dividend yield N/A
200-day MA $6.82 Market Cap 3.47M

RKDA Stock Price Chart Interactive Chart >


  • RKDA scores best on the Sentiment dimension, with a Sentiment rank ahead of 64.57% of US stocks.
  • The strongest trend for RKDA is in Value, which has been heading down over the past 110 days.
  • RKDA's current lowest rank is in the Stability metric (where it is better than 0.48% of US stocks).

RKDA Stock Summary

  • RKDA has a market capitalization of $3,602,404 -- more than approximately merely 1.94% of US stocks.
  • In terms of volatility of its share price, RKDA is more volatile than 95.1% of stocks we're observing.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for RKDA comes in at -305.3% -- higher than that of just 2.22% of stocks in our set.
  • Stocks that are quantitatively similar to RKDA, based on their financial statements, market capitalization, and price volatility, are TREE, AQB, AVNS, AOUT, and SWBI.
  • Visit RKDA's SEC page to see the company's official filings. To visit the company's web site, go to

RKDA Valuation Summary

  • RKDA's price/earnings ratio is -0.2; this is 101.01% lower than that of the median Consumer Defensive stock.
  • Over the past 102 months, RKDA's EV/EBIT ratio has gone up 19.3.

Below are key valuation metrics over time for RKDA.

Stock Date P/S P/B P/E EV/EBIT
RKDA 2023-09-22 0.6 0.2 -0.2 0.5
RKDA 2023-09-21 0.6 0.2 -0.2 0.5
RKDA 2023-09-20 0.6 0.2 -0.2 0.5
RKDA 2023-09-19 0.7 0.2 -0.2 0.5
RKDA 2023-09-18 0.7 0.2 -0.2 0.5
RKDA 2023-09-15 0.7 0.2 -0.3 0.5

RKDA Growth Metrics

    Its year over year net cashflow from operations growth rate is now at -1.52%.
  • Its 4 year net cashflow from operations growth rate is now at -34.48%.
  • Its 4 year revenue growth rate is now at -60.64%.
Over the past 67 months, RKDA's revenue has gone up $7,773,000.

The table below shows RKDA's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 11.127 -18.281 -20.414
2022-06-30 11.625 -23.178 -19.722
2022-03-31 9.172 -26.046 -21.206
2021-12-31 6.78 -25.868 -14.66
2021-09-30 11.739 -25.959 3.52
2021-06-30 9.677 -24.61 -0.696

RKDA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • RKDA has a Quality Grade of D, ranking ahead of 12.03% of graded US stocks.
  • RKDA's asset turnover comes in at 0.174 -- ranking 14th of 16 Agriculture stocks.
  • CVGW, SISI, and ALCO are the stocks whose asset turnover ratios are most correlated with RKDA.

The table below shows RKDA's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.174 0.378 -0.027
2021-03-31 0.180 0.307 -0.180
2020-12-31 0.212 0.353 -0.196
2020-09-30 0.039 -2.048 -0.944
2020-06-30 0.040 -0.688 -1.479
2020-03-31 0.041 0.273 -0.884

RKDA Price Target

For more insight on analysts targets of RKDA, see our RKDA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $6.23 Average Broker Recommendation 1.5 (Moderate Buy)

Arcadia Biosciences, Inc. (RKDA) Company Bio

Arcadia Biosciences, Inc. develops and commercializes agricultural products that enhance the environment and human health. It offers crop productivity and product quality traits for various crops. The company was founded in 2002 and is based in Davis, California.

RKDA Latest News Stream

Event/Time News Detail
Loading, please wait...

RKDA Latest Social Stream

Loading social stream, please wait...

View Full RKDA Social Stream

Latest RKDA News From Around the Web

Below are the latest news stories about ARCADIA BIOSCIENCES INC that investors may wish to consider to help them evaluate RKDA as an investment opportunity.

Arcadia Biosciences (RKDA) to Participate in Upcoming Investor Conferences

DAVIS, Calif., September 05, 2023--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced today that Stan Jacot, president and CEO and T.J. Schaefer, CFO, will be participating in two investor conferences during the month of September.

Yahoo | September 5, 2023

3 Stocks to Watch in the Thriving Agriculture - Products Industry

The Agriculture - Products industry is set to gain from solid demand. Stocks like Bunge (BG), Andersons (ANDE) and Arcadia Biosciences (RKDA) are poised to ride on this positive trend.

Yahoo | September 1, 2023

Q2 2023 Arcadia Biosciences Inc Earnings Call

Q2 2023 Arcadia Biosciences Inc Earnings Call

Yahoo | August 11, 2023

Arcadia Biosciences (RKDA) Reports Q2 Loss, Misses Revenue Estimates

Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of 46.34% and 2.87%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | August 10, 2023

Arcadia Biosciences (RKDA) Announces Second-Quarter and First-Half 2023 Financial Results and Business Highlights

DAVIS, Calif., August 10, 2023--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the second quarter and first half of 2023.

Yahoo | August 10, 2023

Read More 'RKDA' Stories Here

RKDA Price Returns

1-mo N/A
3-mo -26.83%
6-mo N/A
1-year -85.95%
3-year -97.27%
5-year -98.35%
YTD -71.13%
2022 -73.94%
2021 -58.89%
2020 -53.83%
2019 72.87%
2018 -42.36%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!